The proliferative subtype was identified by the overexpression of transcription factors HMGA2 and SOX11, proliferation marker genes such as MCM2 and PCNA, and underexpression of MUC1 and MUC16, which are known ovarian tumor marker genes. The gene discussed is HMGA2; the disease is ovarian neoplasm.